Interleukins and Contrasuppression Induce Immune Regression of Head and Neck Cancer

This publication has 18 references indexed in Scilit:

• Interleukin 1 regulates secretion of zinc-thymulin by human thymic epithelial cells and its action on T-lymphocyte proliferation and nuclear protein kinase C.
  Proceedings of the National Academy of Sciences, 1992
• Mixed interleukins (BC-IL) and thymosin fraction V synergistically induce T lymphocyte development in hydrocortisone-treated adult mice
  International Journal of Immunopharmacology, 1991
• Clinical and Immunopathological Results of a Phase II Study of Perilymphatically Injected Recombinant Interleukin-2 in Locally Far Advanced, Nonpretreated Head and Neck Squamous Cell Carcinoma
  Journal of Immunotherapy, 1991
• Strategies of immune reconstitution: Effects of lymphokines on murine T cell development in vitro and in vivo
  Life Sciences, 1989
• Adjuvant chemotherapy for advanced head and neck squamous carcinoma
  Cancer, 1987
• Lymphokine Production and Lymphocyte Subpopulations in Patients With Head and Neck Squamous Carcinoma
  JAMA Otolaryngology–Head & Neck Surgery, 1984
• Indomethacin sensitive suppressor cell activity in head and neck cancer patients pre- and post-irradiation therapy
  Plastic and Reconstructive Surgery, 1983
• Radiotherapy and Head and Neck Cancer: Role of Lymphocyte Response and Clinical Stage
  JAMA Otolaryngology–Head & Neck Surgery, 1980
• Deficient cell‐mediated immunity in head and neck cancer patients secondary to autologous suppressive immune cells
  The Laryngoscope, 1978
• Serial studies of immunocompetence in head and neck cancer patients undergoing radiation therapy
  American Journal of Roentgenology, 1976